97 related articles for article (PubMed ID: 3718681)
1. Onset and growth rate of solid tumours derived from implanted ascites tumour cells pretreated with ascorbic acid.
Liotti FS; Locci P
Boll Ist Sieroter Milan; 1986; 65(1):61-4. PubMed ID: 3718681
[TBL] [Abstract][Full Text] [Related]
2. Absence of accumulation phenomena in normal and tumoral tissues of mice treated with ascorbic acid.
Liotti FS; Talesa V; Menghini AR
Int J Vitam Nutr Res; 1983; 53(3):251-7. PubMed ID: 6629664
[TBL] [Abstract][Full Text] [Related]
3. Device for intracellular increase of oxygen free radicals and inhibition of MethA tumour cell proliferation: in vitro and in vivo studies.
Mashiba H; Matsunaga K
Int J Tissue React; 1988; 10(5):273-80. PubMed ID: 2855073
[TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibitory effects of hyperthermia combined with ascorbic acid on DNA synthesis in Ehrlich ascites tumor cells grown at a low cell density.
Kageyama K; Onoyama Y; Otani S; Matsui-Yuasa I; Nagao N; Miwa N
Cancer Biochem Biophys; 1995 Jan; 14(4):273-80. PubMed ID: 7767901
[TBL] [Abstract][Full Text] [Related]
5. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
Benedict WF; Wheatley WL; Jones PA
Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
[TBL] [Abstract][Full Text] [Related]
6. Stimulating effect of ascorbic acid on ascites tumor cell multiplication in vitro.
Liotti FS; Bodo M; Talesa V
J Cancer Res Clin Oncol; 1983; 106(1):69-70. PubMed ID: 6885899
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs.
Osmak M; Kovacek I; Ljubenkov I; Spaventi R; Eckert-Maksić M
Neoplasma; 1997; 44(2):101-7. PubMed ID: 9201289
[TBL] [Abstract][Full Text] [Related]
8. Augmented inhibition of tumor cell proliferation in the combined use of disulfiram with ascorbic acid and the involvement of oxygen free radicals.
Mashiba H; Matsunaga K
Jpn J Exp Med; 1990 Aug; 60(4):209-14. PubMed ID: 2292808
[TBL] [Abstract][Full Text] [Related]
9. Effects of ascorbic and dehydroascorbic acid on the multiplication of tumor ascites cells in vitro.
Liotti FS; Menghini AR; Guerrieri P; Talesa V; Bodo M
J Cancer Res Clin Oncol; 1984; 108(2):230-2. PubMed ID: 6470029
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis reveals upregulation of RKIP in S-180 implanted BALB/C mouse after treatment with ascorbic acid.
Park S; Ahn ES; Lee S; Jung M; Park JH; Yi SY; Yeom CH
J Cell Biochem; 2009 Apr; 106(6):1136-45. PubMed ID: 19224539
[TBL] [Abstract][Full Text] [Related]
11. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
[TBL] [Abstract][Full Text] [Related]
12. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
[TBL] [Abstract][Full Text] [Related]
13. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
Paulsen JE; Elgjo K
In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
[TBL] [Abstract][Full Text] [Related]
14. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
Sarna S; Bhola RK
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
16. Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis.
Campbell JD; Cole M; Bunditrutavorn B; Vella AT
Cell Immunol; 1999 May; 194(1):1-5. PubMed ID: 10357874
[TBL] [Abstract][Full Text] [Related]
17. Vascular stroma-derived endothelial colony forming progenitor cells adapt to tumour growth.
Lincoln DT; Kaiser HE; Abul HT; al-Jarallah MA
In Vivo; 2002; 16(6):479-92. PubMed ID: 12494892
[TBL] [Abstract][Full Text] [Related]
18. [Biological activity of urocanic acid].
Burobin VA; Ponomareva OV; Nikolaeva TG; Iurchenko NIa
Vopr Med Khim; 1985; 31(1):102-6. PubMed ID: 3984264
[TBL] [Abstract][Full Text] [Related]
19. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
20. Ascorbic acid-independent synthesis of collagen in mice.
Parsons KK; Maeda N; Yamauchi M; Banes AJ; Koller BH
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1131-9. PubMed ID: 16352673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
